IP Verse

Senju Pharmaceutical competitive analysis

Loading summary...

Latest PTAB cases involving Senju Pharmaceutical

Discover the latest PTAB cases involving Senju Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 9, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Senju Pharmaceutical

IPR2016-01163Jun 8, 2016MYLAN PHARMACEUTICALSSENJU PHARMACEUTICALSTerminated-Settled
IPR2016-00626Feb 25, 2016MYLAN PHARMACEUTICALSSENJU PHARMACEUTICALTerminated-Settled
IPR2016-00089Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2016-00090Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2016-00091Nov 2, 2015INNOPHARMA LICENSINGSENJU PHARMACEUTICALFinal Written Decision
IPR2015-01871Sep 4, 2015LUPINSENJU PHARMACEUTICALFinal Written Decision
IPR2015-01205May 15, 2015AKORNSENJU PHARMACEUTICALFinal Written Decision
IPR2015-01097Apr 23, 2015LUPINSENJU PHARMACEUTICALFinal Written Decision
IPR2015-01099Apr 23, 2015LUPINSENJU PHARMACEUTICALFinal Written Decision
IPR2015-01100Apr 23, 2015LUPINSENJU PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Senju Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SENJU PHARMACEUTICAL - - - 14
INNOPHARMA LICENSING - - 7 -
LUPIN - 115 -
METRICS - - 2 -